Clinical Spectrum and Therapeutic Options in Monogenic CTLA-4-, LRBA-, or SOCS1-Related Primary Immune Regulatory Disorders.

Wang C, Durkee-Shock J, Ma CA, Calvo KR, Kleiner DE, Pittaluga S, Uzel G

Open source

DOI
10.1016/j.jaip.2026.02.039
Published
2026 Jul
Container
The journal of allergy and clinical immunology. In practice
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaip.2026.02.039,
  title = {Clinical Spectrum and Therapeutic Options in Monogenic CTLA-4-, LRBA-, or SOCS1-Related Primary Immune Regulatory Disorders.},
  author = {Wang C and Durkee-Shock J and Ma CA and Calvo KR and Kleiner DE and Pittaluga S and Uzel G},
  year = {2026},
  journal = {The journal of allergy and clinical immunology. In practice},
  doi = {10.1016/j.jaip.2026.02.039},
  url = {https://doi.org/10.1016/j.jaip.2026.02.039}
}

RIS

TY  - JOUR
TI  - Clinical Spectrum and Therapeutic Options in Monogenic CTLA-4-, LRBA-, or SOCS1-Related Primary Immune Regulatory Disorders.
AU  - Wang C
AU  - Durkee-Shock J
AU  - Ma CA
AU  - Calvo KR
AU  - Kleiner DE
AU  - Pittaluga S
AU  - Uzel G
PY  - 2026
JO  - The journal of allergy and clinical immunology. In practice
DO  - 10.1016/j.jaip.2026.02.039
UR  - https://doi.org/10.1016/j.jaip.2026.02.039
ER  - 

APA

C, W., J, D., CA, M., KR, C., DE, K., S, P., & G, U. (2026). Clinical Spectrum and Therapeutic Options in Monogenic CTLA-4-, LRBA-, or SOCS1-Related Primary Immune Regulatory Disorders.. The journal of allergy and clinical immunology. In practice. https://doi.org/10.1016/j.jaip.2026.02.039

Source records